National pharmaceutical producers should be supported with state orders, says MP
Support for national pharmaceutical manufacturers should be given through state orders, Head of the parliamentary healthcare committee Olha Bohomolets has said.
"State orders for a period of three to five years could stimulate the development of national pharmaceutical producers. Then national producers will be ready to open new production lines, invest funds and create new jobs," she said in an interview with Interfax-Ukraine.
Bohomolets also said that Ukrainian pharmaceutical companies are businesses, which along with the creation of new jobs could develop and sell products aboard.
She said that in the near future Ukraine will not start producing innovative drugs, including drugs for treating rare diseases.
She said that transparent state procurement should begin over the supply of innovation drugs to the country, while Ukrainian pharmaceutical companies could produce other drugs, for example, generics.
Advertising
Advertising
MORE ABOUT
Decline in demand for Darnitsa's products can be due to failure to lower prices after canceling marketing payments
10:05, 18.09.2025
Antimonopoly Committee fines Ukraine's 2 largest pharma distributors UAH 4.8 bln
10:41, 01.08.2025
Bohomolets: Martynenko did everything to make Ukraine better
21:05, 29.05.2024
Pharmaceutical firm Darnitsa could attract loans of up to UAH 5 bln within one year
21:01, 30.04.2024
Activists propose ban intl pharmaceutical companies that continue work in Russia from taking part in state tenders
18:52, 18.08.2022
LATEST
Ukraine's State Agency revises claims about UAH 6.6 bln road through Bukovel
20:30, 05.12.2025
G7, EU countries considering complete ban on oil transportation from Russia instead of price cap – media
20:29, 05.12.2025
Intl support for humanitarian demining since 2022 reaches nearly $1.5 bln – Economy Minister
19:42, 05.12.2025
Eighty-three candidates apply for four Energoatom Supervisory Board seats
14:02, 05.12.2025
Vodafone Ukraine announces another buy-out of eurobonds for $1.16 mln